Creogenic Pharma
APRIL 15, 2023
1* Pharma Franchise Company Submit Lowest Price 250+ Products Best Service Best Quality Just a few decades ago Baddi was a town of dust. The land was dull and there were next to zero companies there. We have a vast network of customers throughout the nation who trust us for our quality and affordable products.
Drug Discovery World
AUGUST 22, 2023
Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. What are complex generics?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
APRIL 12, 2021
A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. The adulterated product was found to have caused nine patient deaths and 574 serious adverse events (SAEs).
Pharmaceutical Technology
JULY 15, 2022
California’s budget documents give few details about the tender process, but state that CalRx will spend $50 million to partner with a contract manufacturer to develop biosimilar insulin products in vial and pen form. This CMO will be responsible for product roll-out and distribution. In-house manufacturing the norm.
Camargo
NOVEMBER 11, 2020
Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. In October, the U.S.
Pharmaceutical Technology
FEBRUARY 24, 2023
EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies. But others do not accept that the EU is less competitive for the pharma industry than North America and Asia.
pharmaphorum
SEPTEMBER 9, 2022
tons of carbon dioxide equivalent (CO 2 e) for every $1m it generated – placing it above even the automotive industry, which emitted 31.4 tons per $1m generated in the same year, in terms of contributing to global greenhouse gases (GHGs). “As In 2019, the pharmaceutical industry produced 48.55 Vulnerability . Adaptability.
Expert insights. Personalized for you.
40 
Let's personalize your content